Overview
- Provides detailed up-to-date information on the full range of treatment strategies for multiple myeloma, with due attention to individualized therapy and supportive options
- Also discusses history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems
- Written by acknowledged experts
- Includes supplementary material: sn.pub/extras
Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 183)
Buy print copy
About this book
Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.
Similar content being viewed by others
Keywords
Table of contents (15 chapters)
-
Front Matter
-
History and Epidemiology
-
Front Matter
-
-
Pathophysiology
-
Front Matter
-
-
Clinical Features
-
Front Matter
-
-
Therapy
-
Front Matter
-
Editors and Affiliations
Bibliographic Information
Book Title: Multiple Myeloma
Editors: Thomas Moehler, Hartmut Goldschmidt
Series Title: Recent Results in Cancer Research
DOI: https://doi.org/10.1007/978-3-540-85772-3
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2011
Hardcover ISBN: 978-3-540-85771-6Published: 22 April 2011
Softcover ISBN: 978-3-642-26799-4Published: 30 May 2013
eBook ISBN: 978-3-540-85772-3Published: 21 April 2011
Series ISSN: 0080-0015
Series E-ISSN: 2197-6767
Edition Number: 1
Number of Pages: XXIV, 340
Topics: Oncology, Hematology, Cancer Research